Jump to content

Clyde A. Hutchison III

Add links
From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Citation bot (talk | contribs) at 07:58, 27 August 2023 (Add: series. Removed parameters. Some additions/deletions were parameter name changes. | Use this bot. Report bugs. | #UCB_CommandLine). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

This article is about the biochemist and microbiologist. For his chemist father, see Clyde A. Hutchison, Jr.
Clyde A. Hutchison III
NationalityAmerican
EducationYale University
Alma materCalifornia Institute of Technology
Known forResearch on site-directed mutagenesis and synthetic biology
Scientific career
FieldsBiochemistry, microbiology
InstitutionsUniversity of North Carolina at Chapel Hill, J. Craig Venter Institute

Clyde A. Hutchison III is an American biochemist and microbiologist notable for his research on site-directed mutagenesis and synthetic biology. He is Professor Emeritus of Microbiology and Immunology at the University of North Carolina at Chapel Hill, distinguished professor at the J Craig Venter Institute, a member of the National Academy of Sciences, and a fellow of the American Academy of Arts and Sciences.[1]

Early research

Hutchison graduated from Yale University in 1960, with a B.S. degree in physics. He studied for his PhD at Caltech, working on the bacteriophage ΦX174. While at Caltech he began a long-term collaboration with Marshall Edgell.[1] In 1968 he moved to UNC-Chapel Hill. Hutchison and Edgell used restriction enzymes for the analysis of ΦX174 and mammalian DNA.

Hutchison participated in the determination of the first complete sequence of a DNA molecule (ΦX174) when he spent a year sabbatical at the Frederick Sanger's laboratory in 1975/1976.[2]

Site-directed mutagenesis

In 1971, Clyde Hutchison and Marshall Edgell showed that it is possible to produce mutants with small fragments of bacteriophage ϕX174 and restriction nucleases.[3][4] Hutchison later collaborated with Michael Smith and developed a more general method of site-directed mutagenesis using a mutant oligonucleotide primer and DNA polymerase. Smith and Hutchison used a 12-nucleotide oligomer with a centrally positioned single mismatched nucleotide as primer, a circular single-stranded ϕX174 DNA as template, and E. coli DNA polymerase I in which the 5'-exonuclease had been inactivated by subtilisin. The polymerization with the primer annealed to the template generated a double-stranded DNA product that contained a mutation and could be converted to a closed circular duplex by enzymatic ligation.[5] Transfection of E. coli with this molecule produced a mixed population of wild-type and mutated phage DNA. For his part in the development of this process, Michael Smith later shared the Nobel Prize in Chemistry in 1993 with Kary B. Mullis, who invented polymerase chain reaction.[6]

Hutchison later developed methods for "complete mutagenesis" in which each residue in a protein is individually altered.[7]

Synthetic biology

In 1990 Hutchison began work on Mycoplasma genitalium, which has the smallest known genome that can constitute a cell. It led to a collaboration with The Institute for Genomic Research (TIGR) to sequence the entire genome of the organism in 1995. In 1996 Hutchison spent a sabbatical year at TIGR; there he discussed with Hamilton Smith and Craig Venter the idea of a minimum cell - cell with the minimal set of genes required for survival.[8] They speculated that they may need to synthesize the genome to test them in recipient cell, thereby creating a synthetic cell.

In 2003 Hutchison began a collaboration with Hamilton Smith on the assembly of a synthetic minimal cellular genome, and successfully synthesized the small genome (5386 base pairs) of the bacteriophage ΦX174. The M. genitalium genome however is over 100 times larger than that of ΦX174. In 2007, a chemically synthesized genome of 582,970 base pairs based on M. genitalium, intended for the creation of an organism christened Mycoplasma laboratorium, was successfully assembled.[9] M. genitalium however is slow-growing and attempts at transplanting its genome to another species became protracted and proved unsuccessful. The synthetic-cell team however showed that it is possible to transplant the natural genome of Mycoplasma mycoides, whose genome is twice the size of M. genitalium, into a related species Mycoplasma capricolum.[10] The team therefore decided to switch to the faster-growing M. mycoides as the donor species. In March 2010, a synthesized M. mycoides genome was successfully transplanted into M. capricolum.[8][11] The resulting organism was called "Synthia" by the popular press.[8] In 2016, the team revealed a further pared-down version of the organism with 473 genes, 149 of which whose functions are completely unknown.[12]

Work on creating the minimal cell is currently in progress. New versions of the synthetic genome with genes removed are transplanted into recipient cells, and the resultant cells' growth rates and their colony size are monitored. Other more complex bacteria such as cyanobacteria are also being assessed for the feasibility of genome transplantation.[8]

References

  1. ^ a b "Clyde A. Hutchison III - a brief career sketch". University of North Carolina at Chapel Hill.
  2. ^ Sanger F, Coulson AR, Friedmann T, Air GM, Barrell BG, Brown NL, Fiddes JC, Hutchison CA 3rd, Slocombe PM, Smith M (1978). "The nucleotide sequence of bacteriophage phiX174". Journal of Molecular Biology. 125 (2): 225–46. doi:10.1016/0022-2836(78)90346-7. PMID 731693.
  3. ^ Hutchison III, C. A.; Edgell, M. H. (1971). "Genetic Assay for Small Fragments of Bacteriophage φX174 Deoxyribonucleic Acid". Journal of Virology. 8 (2): 181–189. doi:10.1128/JVI.8.2.181-189.1971. PMC 356229. PMID 4940243.
  4. ^ Marshall H. Edgell; Clyde A. Hutchison & III, Morton Sclair (1972). "Specific Endonuclease R Fragments of Bacteriophage X174 Deoxyribonucleic Acid". Journal of Virology. 9 (4): 574–582. doi:10.1128/JVI.9.4.574-582.1972. PMC 356341. PMID 4553678.
  5. ^ Hutchison, C.A.; Phillips, S.; Edgell, M.H.; Gillham, S.; Jahnke, P.; Smith, M. (1978). "Mutagenesis at a Specific Position in a DNA Sequence" (PDF). Journal of Biological Chemistry. 253 (18): 551–6560. doi:10.1016/S0021-9258(19)46967-6. PMID 681366.
  6. ^ Nicole Kresge; Robert D. Simoni; Robert L. Hill. "The Development of Site-directed Mutagenesis by Michael Smith" (PDF). Journal of Biological Chemistry. 281 (39).
  7. ^ Hutchison, C.A. III; Swanstrom, R. & Loeb, D.D. (1991). Complete Mutagenesis of Protein Coding Domains. Methods in Enzymology. Vol. 202. pp. 356–390. doi:10.1016/0076-6879(91)02019-6. ISBN 9780121821036. PMID 1784182.
  8. ^ a b c d Roberta Kwok (2010). "Genomics: DNA's master craftsmen". Nature. 468 (7320): 22–5. Bibcode:2010Natur.468...22K. doi:10.1038/468022a. PMID 21048740.
  9. ^ Ed Pilkington (6 October 2007). "I am creating artificial life, declares US gene pioneer". Guardian.
  10. ^ Lartigue C, Glass JI, Alperovich N, Pieper R, Parmar PP, Hutchison CA 3rd, Smith HO, Venter JC (2007). "Genome transplantation in bacteria: changing one species to another". Science. 317 (5838): 632–8. Bibcode:2007Sci...317..632L. CiteSeerX 10.1.1.395.4374. doi:10.1126/science.1144622. PMID 17600181. S2CID 83956478.
  11. ^ Gibson DG, Glass JI, Lartigue C, Noskov VN, Chuang RY, Algire MA, Benders GA, Montague MG, Ma L, Moodie MM, Merryman C, Vashee S, Krishnakumar R, Assad-Garcia N, Andrews-Pfannkoch C, Denisova EA, Young L, Qi ZQ, Segall-Shapiro TH, Calvey CH, Parmar PP, Hutchison CA 3rd, Smith HO, Venter JC (2010). "Creation of a bacterial cell controlled by a chemically synthesized genome". Science. 329 (5987): 52–6. Bibcode:2010Sci...329...52G. doi:10.1126/science.1190719. PMID 20488990.
  12. ^ Ed Yong (March 24, 2016). "The Mysterious Thing About a Marvelous New Synthetic Cell".
Retrieved from "https://en.wikipedia.org/w/index.php?title=Clyde_A._Hutchison_III&oldid=1172466801"